Ludovic J Chassin
Overview
Explore the profile of Ludovic J Chassin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
874
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Plank J, Blaha J, Cordingley J, Wilinska M, Chassin L, Morgan C, et al.
Diabetes Care
. 2006 Jan;
29(2):271-6.
PMID: 16443872
Objective: To evaluate a fully automated algorithm for the establishment of tight glycemic control in critically ill patients and to compare the results with different routine glucose management protocols of...
12.
Chassin L, Wilinska M, Hovorka R
Diabetes Technol Ther
. 2005 Mar;
7(1):72-82.
PMID: 15738705
Closed-loop control of the glucose concentration in type 1 diabetes has been the subject of extensive research over the last 3 decades. Building on the recent progress in continuous glucose...
13.
Wilinska M, Chassin L, Schaller H, Schaupp L, Pieber T, Hovorka R
IEEE Trans Biomed Eng
. 2005 Jan;
52(1):3-12.
PMID: 15651559
We investigated insulin lispro kinetics with bolus and continuous subcutaneous insulin infusion (CSII) modes of insulin delivery. Seven subjects with type-1 diabetes treated by CSII with insulin lispro have been...
14.
Wilinska M, Bodenlenz M, Chassin L, Schaller H, Schaupp L, Pieber T, et al.
Metabolism
. 2004 Nov;
53(11):1484-91.
PMID: 15536606
We investigated the dynamic relationship between interstitial glucose (IG) in the subcutaneous adipose tissue and plasma glucose (PG) during physiologic conditions in type 1 diabetes mellitus (T1DM). Nine subjects with...
15.
Chassin L, Wilinska M, Hovorka R
Artif Intell Med
. 2004 Nov;
32(3):171-81.
PMID: 15531149
Objective: Adaptive systems to deliver medical treatment in humans are safety-critical systems and require particular care in both the testing and the evaluation phase, which are time-consuming, costly, and confounded...
16.
Hovorka R, Canonico V, Chassin L, Haueter U, Massi-Benedetti M, Federici M, et al.
Physiol Meas
. 2004 Sep;
25(4):905-20.
PMID: 15382830
A nonlinear model predictive controller has been developed to maintain normoglycemia in subjects with type 1 diabetes during fasting conditions such as during overnight fast. The controller employs a compartment...
17.
Hovorka R, Chassin L, Wilinska M, Canonico V, Akwi J, Federici M, et al.
Diabetes Technol Ther
. 2004 Jun;
6(3):307-18.
PMID: 15198833
The objective of the project Advanced Insulin Infusion using a Control Loop (ADICOL) was to develop a treatment system that continuously measures and controls the glucose concentration in subjects with...
18.
Hovorka R, Shojaee-Moradie F, Carroll P, Chassin L, Gowrie I, Jackson N, et al.
Am J Physiol Endocrinol Metab
. 2002 Apr;
282(5):E992-1007.
PMID: 11934663
We have separated the effect of insulin on glucose distribution/transport, glucose disposal, and endogenous production (EGP) during an intravenous glucose tolerance test (IVGTT) by use of a dual-tracer dilution methodology....
19.
Albarrak A, Luzio S, Chassin L, Playle R, Owens D, Hovorka R
J Clin Endocrinol Metab
. 2002 Jan;
87(1):198-203.
PMID: 11788647
We examined the ability of indices of insulin sensitivity and pancreatic beta-cell responsiveness to explain interindividual variability of clinical measures of glucose control in newly presenting type 2 diabetes. Subjects...